ARS Pharmaceuticals, Inc.
A biopharmaceutical company developing treatments for patients with severe allergic diseases. The company is developing a safe, effective, needle-free, easy-to-administer epinephrine nasal spray for the treatment of allergic reactions that can lead to life-threatening anaphylaxis. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 24 |
Founded | 2015 |
Financials | |
|---|---|
Market Capitalization | 1.10B |
Revenue | 0.01M |
Operating Income | -62.00M |
Operating Margin | -619990.00% |
Net Income | -49.70M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4564 / 5373 |
Sector : Healthcare | 771 / 1144 |
Industry : Biotechnology | 359 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 2386 / 5565 |
Sector : Healthcare | 306 / 1182 |
Industry : Biotechnology | 121 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4344 / 5436 |
Sector : Healthcare | 707 / 1164 |
Industry : Biotechnology | 338 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4746 / 5330 |
Sector : Healthcare | 931 / 1174 |
Industry : Biotechnology | 472 / 667 |